Skip to main content
. 2016 Nov 24;6:253. doi: 10.3389/fonc.2016.00253

Table 2.

Hazard ratio (HR) for clinical factors and PFS (patients with missing scores were omitted).

Factors N (n progr.) HR Univariate
Multivariate
95% CI p-Value HR 95% CI p-Value
Age 29 0.98 0.94–1.03 0.600
Fuhrman tumor grade
Grade 2 14 (7) 1
Grade >2 13 (4) 0.39 0.11–1.41 0.393
Performance status
0 18 (6) 1
1 13 (7) 2.26 0. 75–6.77 0.146
Heng classification
Good 11 (6) 1
Intermediate 14 (7) 0.84 0.28–2.53 0.761
Neutrophyle-to-lymphocyte
NLR <3 20 (10) 1
NLR ≥3 4 (3) 2.49 0.68–9.20 0.169 6.92 1.09–44.03 0.040
Urine biomarker score 29 4.62 1.66–12.83 0.003 5.38 1.65–17.57 0.005
Plasma biomarker score 30 1.69 0.71–4.01 0.232